NUCLEOLIN and cancer: AS1411 is an aptamer that specifically binds to the surface and cytoplasmic nucleolin molecules, and a promising agent with demonstrated clinical efficacy and low toxicity, and due to these facts, AS1411 was studied in several human clinical anti-cancer trials40,41.